Adult Congenital Heart Disease Research
Investigator-Initiated Research
| Principal Investigator | Study Title | Funding Agencies |
| Theodore Abraham, MD | UCSF HCM Registry | Internal Funding |
| Anu Agarwal, MD | Clinical characteristics and outcomes of patients with congenital heart disease at a tertiary care center | Internal Funding |
| Michelle Albert, MD | A National Multicenter Retrospective Review of Stress-Induced Cardiomyopathy (Takotsubo Syndrome) Cases in the United States | Internal Funding |
| Ian Harris, MD | Role of Cardiovascular Magnetic Resonance in Pregnant Patients with Cardiovascular Disease | Internal Funding |
| Nisha Parikh, MD | Reproductive Factors, Cardiovascular Disease Risk Factors and Coronary Heart Disease Risk Stratification in Women | American Heart Assn. (National Office) |
| Nisha Parikh, MD | Pregnancy Related Factors, Cardiovascular Disease Risk Factors and Cardiovascular Disease Risk Stratification | NIH Natl Heart, Lung & Blood Institute |
| Nisha Parikh, MD | Copy of gestational diabetes phenotypes and cardiovascular risk factors | NIH Miscellaneous Other |
| Zian Tseng, MD | Long-Term Arrhythmia Outcomes, Heart Failure and Mortality in Adults with Moderate or Complex Congenital Heart Disease | Internal Funding |
Clinical Trials
| Principal Investigator | Study Title | Funding Agencies |
| Theodore Abraham, MD | A Long-Term Safety Extension Study of Mavacamten (MYK-461) in Adults with Hypertrophic Cardiomyopathy Who Have Completed the MAVERICK-HCM (MYK-461-006) or EXPLORER-HCM (MYK-461-005) Trials (MAVA-LTE). | Myokardia |
| Theodore Abraham, MD | A multi-center, randomized, double-blind, placebo-controlled, dose-finding study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of CK-3773274 in adults with symptomatic hypertrophic cardiomyopathy and left ventricular outflow tract obstruction. | Cytokinetics |